Hepatic ischemia/reperfusion injury associates with acute kidney injury in liver transplantation: Prospective cohort study
- 24 April 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 23 (5) , 634-644
Abstract
Solid clinical prospective studies investigating the association between hepatic ischemia/reperfusion injury (HIRI) and acute kidney injury (AKI) after liver transplantation are missing. HIRI, reflected by transaminase release, induces AKI in rodents, and retrospective studies suggest a similar association in humans. This prospective cohort study determined risk factors for AKI in 80 adult liver‐only recipients. AKI defined by Risk, Injury, Failure, Loss, and End‐Stage Kidney Disease (RIFLE) criteria developed in 21 (26%) recipients at 12 hours after reperfusion (interquartile range, 6 hours to postoperative day [POD] 1); 13 progressed from “risk” to “injury”; 5 progressed to “failure.” In AKI patients, creatinine (Cr) increased during liver transplantation and was higher versus baseline at 6 hours to POD 4, whereas perioperative Cr remained stable in those without AKI. Plasma heart‐type fatty acid–binding protein was higher 12 hours after reperfusion in AKI patients, though urinary kidney injury molecule 1 and neutrophil gelatinase–associated lipocalin were similar between those with or without AKI. Peak aspartate aminotransferase (AST), occurring at 6 hours, was the only independent risk factor for AKI (adjusted odds ratio, 2.42; 95% confidence interval, 1.24‐4.91). Early allograft dysfunction occurred more frequently in AKI patients, and intensive care and hospital stays were longer. Patient survival at 1 year was 90% in those with AKI versus 98% in those without AKI. Chronic kidney disease stage ≥ 2 at 1 year was more frequent in patients who had had AKI (89% versus 58%, respectively). In conclusion, AKI is initiated early after liver reperfusion and its association with peak AST suggests HIRI as a determinant. Identifying operating mechanisms is critical to target interventions and to reduce associated morbidity. Liver Transplantation 23 634–644 2017 AASLD.Keywords
This publication has 33 references indexed in Scilit:
- Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomesBritish Journal of Anaesthesia, 2015
- Hepatic ischemia reperfusion injury is associated with acute kidney injury following donation after brain death liver transplantationTransplant International, 2013
- Renal dysfunction in liver transplant recipients: Evaluation of the critical issuesLiver Transplantation, 2012
- Donation After Cardiac Death Liver Transplant Recipients Have an Increased Frequency of Acute Kidney InjuryAmerican Journal of Transplantation, 2012
- Postliver Transplant Acute Renal Injury and Failure by the RIFLE Criteria in Patients With Normal Pretransplant Serum Creatinine Concentrations: A Matched StudyTransplantation, 2011
- Acute kidney injury after hepatic ischemia and reperfusion injury in miceLaboratory Investigation, 2008
- Acute Renal Disease, as Defined by the RIFLE Criteria, Post-Liver TransplantationAmerican Journal of Transplantation, 2006
- The effects of desferrioxamine and quercetin on hepatic ischemia–reperfusion induced renal disturbanceProstaglandins, Leukotrienes and Essential Fatty Acids, 2006
- Risk factors of acute renal failure after liver transplantationKidney International, 2006
- Acute renal failure following liver transplantation with induction therapyClinical Nephrology, 2006